Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ensysce Biosciences Inc.

2.98
-0.0400-1.32%
Volume:92.18K
Turnover:281.34K
Market Cap:4.90M
PE:-0.26
High:3.19
Open:3.08
Low:2.98
Close:3.02
Loading ...
May 13, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 03, 2024

Correspondence

Form CORRESP - Correspondence
Mar 29, 2024

Major Issues Report

Form 8-K - Current report
Mar 26, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 15, 2024

Major Issues Report

Form 8-K - Current report
Mar 15, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 17, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 29, 2023

Major Issues Report

Form 8-K - Current report
Dec 20, 2023

Major Issues Report

Form 8-K - Current report
Nov 29, 2023

Major Issues Report

Form 8-K - Current report
Nov 21, 2023

Correspondence

Form CORRESP - Correspondence
Nov 18, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 18, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report